抗骨吸收和促骨形成药物在骨质疏松症治疗中的联合应用

被引：40

作者：

李宏超

宋慧

机构：

[1] 北京积水潭医院风湿免疫科

来源：

中国骨质疏松杂志 | 2018年 / 24卷 / 03期

关键词：

骨质疏松症; 促进骨形成; 抑制骨吸收; 联合治疗;

D O I：

暂无

中图分类号：

R580 [];

学科分类号：

摘要：

骨质疏松症是一种以骨量减少、骨组织细微结构受损,导致脆性骨折为特征的一种常见疾病。随着人类寿命延长和老年人口的增加,骨质疏松症患病率持续增高,且所致的疼痛和骨折严重影响患者的生活质量,故骨质疏松症的治疗非常重要。目前抗骨质疏松症药物的疗效和安全性比较明确,是防治骨质疏松症的主要手段,但临床上发现单药治疗作用有限,基于不同的作用机制,有学者提出抗骨质疏松症药物的联合治疗。本文针对抗骨质疏松症药物中的两类即抗骨吸收和促骨形成药物之间的联合应用进展做一综述。

引用

收藏

页码：399 / 405

页数：7

相关论文

共 23 条

[1]

Two-year clinical outcome of denosumab treatment alone and in combination with teriparatide in Japanese treatment-naive postmenopausal osteoporotic women.[J].Yukio Nakamura;Takako Suzuki;Mikio Kamimura;Shota Ikegami;Kohei Murakami;Shigeharu Uchiyama;Akira Taguchi;Hiroyuki Kato;.Bone Research.2017, 02

[2]

原发性骨质疏松症诊治指南(2011年).[J]..中华骨质疏松和骨矿盐疾病杂志.2011, 01

[3]

Daily or Cyclical Teriparatide Treatment in Women With Osteoporosis on no Prior Therapy and Women on Alendronate [J].

Cosman, Felicia ;

Nieves, Jeri W. ;

Zion, Marsha ;

Garrett, Patricia ;

Neubort, Simon ;

Dempster, David ;

Lindsay, Robert .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 100 (07) :2769-2776

[4]

Selective estrogen receptor modulators (SERMs): A review of clinical data [J].

Mirkin, Sebastian ;

Pickar, James H. .

MATURITAS, 2015, 80 (01) :52-57

[5]

Comparative Effects of Teriparatide, Denosumab, and Combination Therapy on Peripheral Compartmental Bone Density, Microarchitecture, and Estimated Strength: the DATA-HRpQCT Study [J].

Tsai, Joy N. ;

Uihlein, Alexander V. ;

Burnett-Bowie, Sherri-Ann M. ;

Neer, Robert M. ;

Zhu, Yuli ;

Derrico, Nicholas ;

Lee, Hang ;

Bouxsein, Mary L. ;

Leder, Benjamin Z. .

JOURNAL OF BONE AND MINERAL RESEARCH, 2015, 30 (01) :39-45

[6]

Anabolic and Antiresorptive Therapy for Osteoporosis: Combination and Sequential Approaches [J].

Cosman, Felicia .

CURRENT OSTEOPOROSIS REPORTS, 2014, 12 (04) :385-395

[7]

Overlapping and Continued Alendronate or Raloxifene Administration in Patients on Teriparatide: Effects on Areal and Volumetric Bone Mineral Density-The CONFORS Study [J].

Muschitz, Christian ;

Kocijan, Roland ;

Fahrleitner-Pammer, Astrid ;

Pavo, Imre ;

Haschka, Judith ;

Schima, Wolfgang ;

Kapiotis, Stylianos ;

Resch, Heinrich .

JOURNAL OF BONE AND MINERAL RESEARCH, 2014, 29 (08) :1777-1785

[8]

Two Years of Denosumab and Teriparatide Administration in Postmenopausal Women With Osteoporosis (The DATA Extension Study): A Randomized Controlled Trial [J].

Leder, Benjamin Z. ;

Tsai, Joy N. ;

Uihlein, Alexander V. ;

Burnett-Bowie, Sherri-Ann M. ;

Zhu, Yuli ;

Foley, Katelyn ;

Lee, Hang ;

Neer, Robert M. .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (05) :1694-1700

[9]

Osteoporosis in the European Union: medical management, epidemiology and economic burden [J].

Hernlund, E. ;

Svedbom, A. ;

Ivergard, M. ;

Compston, J. ;

Cooper, C. ;

Stenmark, J. ;

McCloskey, E. V. ;

Jonsson, B. ;

Kanis, J. A. .

ARCHIVES OF OSTEOPOROSIS, 2013, 8 (1-2)

[10]

Combination therapy with risedronate and teriparatide in male osteoporosis [J].

Walker, Marcella D. ;

Cusano, Natalie E. ;

Sliney, James, Jr. ;

Romano, Megan ;

Zhang, Chiyuan ;

McMahon, Donald J. ;

Bilezikian, John P. .

ENDOCRINE, 2013, 44 (01) :237-246